1. Kurtz RC, Sherlock P. The diagnosis of gastric cancer. Semin Oncol. 1985. 12:11–18.
2. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with
Helicobacter pylori seropositivity. J Natl Cancer Inst. 2006. 98:1445–1452.
Article
3. Abnet CC, Fan JH, Kamangar F, Sun XD, Taylor PR, Ren JS, et al. Self-reported goiter is associated with a significantly increased risk of gastric noncardia adenocarcinoma in a large population-based Chinese cohort. Int J Cancer. 2006. 119:1508–1510.
Article
4. Venturi S, Venturi A, Cimini D, Arduini C, Venturi M, Guidi A. A new hypothesis: iodine and gastric cancer. Eur J Cancer Prev. 1993. 2:17–23.
5. Venturi S, Grossi L, Marra GA, Venturi A, Venturi M. Iodine, Helicobacter pylori, stomach cancer and evolution. European EPI-Marker. 2003. 7:1–7.
6. Gołkowski F, Szybiński Z, Rachtan J, Sokołowski A, Buziak-Bereza M, Trofimiuk M, et al. Iodine prophylaxis--the protective factor against stomach cancer in iodine deficient areas. Eur J Nutr. 2007. 46:251–256.
Article
7. Gulaboglu M, Yildiz L, Celebi F, Gul M, Peker K. Comparison of iodine contents in gastric cancer and surrounding normal tissues. Clin Chem Lab Med. 2005. 43:581–584.
Article
8. Aceves C, Anguiano B, Delgado G. Is iodine a gatekeeper of the integrity of the mammary gland? J Mammary Gland Biol Neoplasia. 2005. 10:189–196.
Article
9. Kandemir EG, Yonem A, Narin Y. Gastric carcinoma and thyroid status. J Int Med Res. 2005. 33:222–227.
Article
10. Syrigos KN, Konstantoulakis MM, Constantoulakis M, Marafelia P, Koutras D, Golematis BC. Thyroid autoantibodies and thyroid function in patients with gastric cancer. Acta Oncol. 1994. 33:905–907.
Article
11. Behrouzian R, Aghdami N. Urinary iodine/creatinine ratio in patients with stomach cancer in Urmia, Islamic Republic of Iran. East Mediterr Health J. 2004. 10:921–924.
Article
12. Venturi S. Letter to the editor. The thyroid gland. Clin Exp. 1998. 1:23.
13. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature. 1996. 379:458–460.
Article
14. Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL, et al. Cloning of the human sodium lodide symporter. Biochem Biophys Res Commun. 1996. 226:339–345.
15. Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med. 2000. 6:871–878.
Article
16. Banerjee RK, Bose AK, Chakraborty TK, De SK, Datta AG. Peroxidase-catalysed iodotyrosine formation in dispersed cells of mouse extrathyroidal tissues. J Endocrinol. 1985. 106:159–165.
Article
17. Promotion of iodized salt in the eastern Mediterranean, middleeast and north Africa. In : report of an inter country meeting; 10-12 April 2000; Dubai- United Arab Emirates. WHO.
18. Solbiati L, Charboneau JW, James EM, Hay ID. Rumack CM, Wilson SR, Charboneau JW, editors. The thyroid gland. Diagnostic Ultrasound. 1998. St. Louis: Mosby;704–705.
19. Rossi M, Negri E, Foschi R, Franceschi S, La Vecchia C. Relation between goiter and autoimmune thyroid disease, and gastric cancer. Int J Cancer. 2007. 120:951–952.
Article
20. Andersson M, Takkouche B, Egli I, Allen HE, de Benoist B. Current global iodine status and progress over the last decade towards the elimination of iodine deficiency. Bull World Health Organ. 2005. 83:518–525.
21. World Health Organization. United Nations Children's Fund. International Council for Control of Iodine Deficiency Disorders. Assessment of the iodine deficiency disorders and monitoring their elimination. 2001. 2nd ed. Geneva: World Health Organization;WHO document WHO/NHD/01.1.
22. Gaitan E. Goitrogens in food and water. Annu Rev Nutr. 1990. 10:21–39.
Article
23. Beletskaia OM. The pathophysiological significance of the low triiodothyronine syndrome with increased clearance in cancer of the stomach and large intestine. Lik Sprava. 1996. (3-4):181–184.
24. Guernsey DL, Leuthauser SW. Correlation of thyroid hormone dose-dependent regulation of K-ras protooncogene expression with oncogene activation by 3-methylcholanthrene: loss of thyroidal regulation in the transformed mouse cell. Cancer Res. 1987. 47:3052–3056.
25. Jameson JL, Weetman AP. Kasper DL, Braunwald E, Fauci AS, editors. Disorders of the thyroid gland. Harrison's Principles. Internal Medicine. 2005. 16th ed. New York: McGraw-Hill;2119.